Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.

Haemostasis Pub Date : 1998-05-01 DOI:10.1159/000022432
M L Bots, F van Kooten, M M Breteler, P E Slagboom, A Hofman, F Haverkate, P Meijer, P J Koudstaal, D E Grobbee, C Kluft
{"title":"Response to activated protein C in subjects with and without dementia. The Dutch Vascular Factors in Dementia Study.","authors":"M L Bots,&nbsp;F van Kooten,&nbsp;M M Breteler,&nbsp;P E Slagboom,&nbsp;A Hofman,&nbsp;F Haverkate,&nbsp;P Meijer,&nbsp;P J Koudstaal,&nbsp;D E Grobbee,&nbsp;C Kluft","doi":"10.1159/000022432","DOIUrl":null,"url":null,"abstract":"<p><p>We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.</p>","PeriodicalId":12910,"journal":{"name":"Haemostasis","volume":"28 3-4","pages":"209-15"},"PeriodicalIF":0.0000,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000022432","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Haemostasis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000022432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19

Abstract

We performed a cross-sectional case-control study among 295 subjects with dementia and 406 control subjects drawn from participants of the Rotterdam Study, a population-based cohort study among subjects aged 55 years or over, and from participants of the Rotterdam Stroke Databank, a hospital-based stroke registry, to evaluate the association of the factor V Leiden mutation and activated protein C (APC) response with dementia and its subtypes. The risk of dementia was 2.11-fold increased among carriers of factor V Leiden mutation relative to subjects lacking factor V Leiden mutation (95% confidence interval, CI, 0.93-4.77). The increased risks of vascular dementia and of Alzheimer's disease were 4.28 (95% CI 1.26-14.5) and 2.15 (95% CI 0.82-5.63), respectively. No association was found for APC response. We showed a nonsignificant twofold increased risk of dementia among subjects with factor V Leiden. The association appeared to be stronger for vascular dementia.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
痴呆患者和非痴呆患者对活化蛋白C的反应。荷兰痴呆研究中的血管因素。
我们对295名痴呆患者和406名对照患者进行了横断病例对照研究,这些患者来自鹿特丹研究的参与者,鹿特丹研究是一项年龄在55岁或以上的人群队列研究,以及鹿特丹卒中数据库(一个基于医院的卒中登记处)的参与者,以评估因子V Leiden突变和活化蛋白C (APC)反应与痴呆及其亚型的关系。与缺乏因子V Leiden突变的受试者相比,因子V Leiden突变携带者患痴呆的风险增加了2.11倍(95%可信区间,CI, 0.93-4.77)。血管性痴呆和阿尔茨海默病的风险分别增加4.28 (95% CI 1.26-14.5)和2.15 (95% CI 0.82-5.63)。APC反应未发现关联。我们发现,在Leiden因子V的受试者中,痴呆的风险增加了两倍。这种关联在血管性痴呆中似乎更强。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction. Comparison of different methods to measure fibrinogen concentration in canine plasma with respect to their sensitivity towards the fibrinogen degradation products X, Y and D. Endothelial function, variables of fibrinolysis and coagulation in smokers and healthy controls. Paroxysmal nocturnal hemoglobinuria and the risk of venous thrombosis: review and recommendations for management of the pregnant and nonpregnant patient. Factor V (His 1299 Arg) in young Turkish patients with cerebral infarct.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1